litlas
Log inCreate account

Alan T. Remaley

Active 1984–2025

234
Papers
30,750
Citations
100
h-index
222
i10-index

Citations

Citations per year for Alan T. Remaley1976: 1 citations1985: 2 citations1986: 1 citations1987: 2 citations1988: 3 citations1990: 1 citations1991: 1 citations1992: 5 citations1993: 5 citations1994: 3 citations1995: 3 citations1996: 5 citations1997: 7 citations1998: 10 citations1999: 20 citations2000: 70 citations2001: 111 citations2002: 145 citations2003: 208 citations2004: 171 citations2005: 140 citations2006: 156 citations2007: 103 citations2008: 118 citations2009: 135 citations2010: 169 citations2011: 183 citations2012: 221 citations2013: 317 citations2014: 313 citations2015: 319 citations2016: 301 citations2017: 280 citations2018: 275 citations2019: 881 citations2020: 1,069 citations2021: 1,129 citations2022: 952 citations2023: 855 citations2024: 1,245 citations2025: 676 citations2026: 28 citations1977–1984: no citations, so these years are not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,423 citing papers, 25.1% of this breakdownChina: 1,381 citing papers, 10.1% of this breakdownUnited Kingdom: 738 citing papers, 5.4% of this breakdownGermany: 604 citing papers, 4.4% of this breakdownItaly: 593 citing papers, 4.3% of this breakdownCanada: 521 citing papers, 3.8% of this breakdownAustralia: 465 citing papers, 3.4% of this breakdownNetherlands: 450 citing papers, 3.3% of this breakdownFrance: 444 citing papers, 3.2% of this breakdownSpain: 417 citing papers, 3.1% of this breakdownJapan: 379 citing papers, 2.8% of this breakdownSweden: 258 citing papers, 1.9% of this breakdown
0%25.1%Other 29.2%

Institutions

Fields

  • Medicine54.9%
  • Biochemistry, Genetics and Molecular Biology31.1%
  • Immunology and Microbiology6.6%
  • Neuroscience1.8%
  • Nursing1.4%
  • Chemistry1.1%
  • Other3.1%

Topics

  • Diabetes, Cardiovascular Risks, and Lipoproteins6%
  • Lipoproteins and Cardiovascular Health5.5%
  • MicroRNA in disease regulation4.3%
  • Cholesterol and Lipid Metabolism4.2%
  • Extracellular vesicles in disease2.9%
  • Peroxisome Proliferator-Activated Receptors2.6%
  • Other74.5%

Coauthors

All papers

Open in search
  1. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

    Authors: Henry N. Ginsberg, Chris J. Packard, M. John Chapman, Jan Borén, Carlos A. Aguilar‐Salinas, Maurizio Averna, Brian A. Ference, Daniel Gaudet, Robert A. Hegele, Sander Kersten, Gary F. Lewis, Alice H. Lichtenstein, Philippe Moulin, Børge G. Nordestgaard, Alan T. Remaley, Bart Staels, Erik S.G. Stroes, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Anne Tybjærg‐Hansen, Jane K. Stock, Alberico L. Catapano - European Heart Journal 2021 cited by 899

  2. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

    Authors: Kasey C. Vickers, Brian T. Palmisano, Bassem M. Shoucri, Robert D. Shamburek, Alan T. Remaley - Nature Cell Biology 2011 cited by 2,705

  3. High-density lipoprotein revisited: biological functions and clinical relevance

    Authors: Arnold von Eckardstein, Børge G. Nordestgaard, Alan T. Remaley, Alberico L. Catapano - European Heart Journal 2022 cited by 370

  4. HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research

    Authors: Anand Rohatgi, Marit Westerterp, Arnold von Eckardstein, Alan T. Remaley, Kerry‐Anne Rye - Circulation 2021 cited by 334

  5. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia

    Authors: Maureen Sampson, Clarence Ling, Qian Sun, Roa Harb, Mohmed Ashmaig, Russell Warnick, Amar A Sethi, James K. Fleming, James D. Otvos, Jeff W. Meeusen, Sarah Delaney, Allan S. Jaffe, Robert D. Shamburek, Marcelo Amar, Alan T. Remaley - JAMA Cardiology 2020 cited by 561

  6. Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation

    Authors: Nathalie Niyonzima, Jubayer Rahman, Natalia Kunz, Erin E. West, Tilo Freiwald, Jigar V. Desai, Nicolas S. Merle, Alexandre Gidon, Bjørnar Sporsheim, Michail S. Lionakis, Kristin Evensen, Beate Rikken Lindberg, Karolina Skagen, Mona Skjelland, Parul Singh, Markus Haug, Marieta M. Ruseva, Martin Kolev, Jack Bibby, Olivia Marshall, Brett A. O’Brien, Nigel Deeks, Behdad Afzali, Richard J. Clark, Trent M. Woodruff, Milton Pryor, Zhihong Yang, Alan T. Remaley, Tom Eirik Mollnes, Stephen M. Hewitt, Bingyu Yan, Majid Kazemian, Máté G. Kiss, Christoph J. Binder, Bente Halvorsen, Terje Espevik, Claudia Kemper - Science Immunology 2021 cited by 161

  7. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

    Authors: Sotirios Tsimikas, Sergio Fazio, Keith C. Ferdinand, Henry N. Ginsberg, Marlys L. Koschinsky, Santica M. Marcovina, Patrick M. Moriarty, Daniel J. Rader, Alan T. Remaley, Gissette Reyes‐Soffer, Raúl D. Santos, George Thanassoulis, Joseph L. Witztum, S. Narasimhan Danthi, Michelle Olive, Lijuan Liu - Journal of the American College of Cardiology 2018 cited by 495

  8. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

    Authors: Børge G. Nordestgaard, Anne Langsted, Samia Mora, Genovefa Kolovou, H Baum, Éric Bruckert, Gerald F. Watts, Grażyna Sypniewska, Olov Wiklund, Jan Borén, M. John Chapman, Christa M. Cobbaert, Olivier Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Kari Pulkki, Florian Kronenberg, Alan T. Remaley, Nader Rifai, Emilio Ros, Michel R. Langlois - European Heart Journal 2016 cited by 835

  9. Cholesterol Efflux and Atheroprotection

    Authors: Robert S. Rosenson, H. Bryan Brewer, W. Sean Davidson, Zahi A. Fayad, Valentı́n Fuster, James Goldstein, Marc K. Hellerstein, Xian‐Cheng Jiang, Michael C. Phillips, Daniel J. Rader, Alan T. Remaley, George H. Rothblat, Alan R. Tall, Laurent Yvan‐Charvet - Circulation 2012 cited by 952

  10. Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

    Authors: Sarfaraz Hasni, Sarthak Gupta, Michael A. Davis, Elaine Poncio, Yenealem Temesgen‐Oyelakin, Philip M. Carlucci, Xinghao Wang, Mohammad Naqi, Martin P. Playford, Rishi R. Goel, Xiaobai Li, Ann Biehl, Isabel Ochoa-Navas, Zerai Manna, Yinghui Shi, Donald E. Thomas, Jinguo Chen, Angélique Biancotto, Richard Apps, Foo Cheung, Yuri Kotliarov, Ashley L. Babyak, Huizhi Zhou, Rongye Shi, Katie Stagliano, Wanxia Li Tsai, Laura Vian, Nathalia Gazaniga, Valentina Giudice, Shajia Lu, Stephen R. Brooks, Meggan Mackay, Peter K. Gregersen, Nehal N. Mehta, Alan T. Remaley, Betty Diamond, John J. O’Shea, Massimo Gadina, Mariana J. Kaplan - Nature Communications 2021 cited by 197

  11. Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain

    Authors: Jeroen F. J. Bogie, Elien Grajchen, Elien Wouters, Aida V. Garcia Corrales, Tess Dierckx, Sam Vanherle, Jo Mailleux, Pascal Gervois, Esther Wolfs, Jonas Dehairs, Jana Van Broeckhoven, Andrew P. Bowman, Ivo Lambrichts, Jan-Ακε Gustafsson, Alan T. Remaley, Monique Mulder, Johannes V. Swinnen, Mansour Haidar, Shane R. Ellis, James M. Ntambi, Noam Zelcer, Jerome J. A. Hendriks - The Journal of Experimental Medicine 2020 cited by 153

  12. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

    Authors: Giulia Chinetti, Sophie Lestavel, Virginie Bocher, Alan T. Remaley, Bernadette Neve, Inès Pineda‐Torra, Elisabeth Teissier, Anne Minnich, Michael Jaye, Nicolas Duverger, H Bryan Brewer, Jean‐Charles Fruchart, Véronique Clavey, Bart Staels - Nature Medicine 2001 cited by 1,165

  13. High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response

    Authors: Andrew Murphy, Kevin Woollard, Anh Hoang, Nigora Mukhamedova, Roslynn A. Stirzaker, Sally P.A. McCormick, Alan T. Remaley, Dmitri Sviridov, Jaye Chin‐Dusting - Arteriosclerosis Thrombosis and Vascular Biology 2008 cited by 509

  14. Metabolite Profiling of a NIST Standard Reference Material for Human Plasma (SRM 1950): GC-MS, LC-MS, NMR, and Clinical Laboratory Analyses, Libraries, and Web-Based Resources

    Authors: Yamil Simón‐Manso, Mark S. Lowenthal, Lisa E. Kilpatrick, Maureen Sampson, Kelly H. Telu, Paul A. Rudnick, W. Gary Mallard, Daniel W. Bearden, Tracey B. Schock, Dmitrii V. Tchekhovskoi, Nikša Blonder, Xinjian Yan, Yuxue Liang, Yufang Zheng, W.E. Wallace, P. Neta, Karen W. Phinney, Alan T. Remaley, Stephen E. Stein - Analytical Chemistry 2013 cited by 303

  15. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

    Authors: Børge G. Nordestgaard, Michel R. Langlois, Anne Langsted, M. John Chapman, Kristin M. Aakre, H Baum, Jan Borén, Éric Bruckert, Alberico L. Catapano, Christa M. Cobbaert, Paul Collinson, Olivier Descamps, Christopher J. Duff, Arnold von Eckardstein, Angelika Hammerer‐Lercher, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Samia Mora, Kari Pulkki, Alan T. Remaley, Nader Rifai, Emilio Ros, Sanja Stanković, Ana Stavljenić-Rukavina, Grażyna Sypniewska, Gerald F. Watts, Olov Wiklund, Päivi Laitinen - Atherosclerosis 2019 cited by 238

  16. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

    Authors: Robert A. Hegele, Jan Borén, Henry N. Ginsberg, Marcello Arca, Maurizio Averna, Christoph J. Binder, Laura Calabresi, M. John Chapman, Marina Cuchel, Arnold von Eckardstein, Ruth Frikke‐Schmidt, Daniel Gaudet, G. Kees Hovingh, Florian Kronenberg, Dieter Lütjohann, Klaus G. Parhofer, Frederick J. Raal, Kausik K. Ray, Alan T. Remaley, Jane K. Stock, Erik S.G. Stroes, Lâle Tokgözoğlu, Alberico L. Catapano - The Lancet Diabetes & Endocrinology 2019 cited by 195

  17. Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor

    Authors: Joaquim Barreto, Sotirios K. Karathanasis, Alan T. Remaley, Andrei C. Spósito - Arteriosclerosis Thrombosis and Vascular Biology 2020 cited by 145

  18. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

    Authors: Fatiha Tabet, Kasey C. Vickers, Luisa Torres, Carrie B. Wiese, Bassem M. Shoucri, Gilles Lambert, Claire Catherinet, Leonel Prado-Lourenço, Michael G. Levin, Seth G. Thacker, Praveen Sethupathy, Philip J. Barter, Alan T. Remaley, Kerry-Anne Rye - Nature Communications 2014 cited by 418

  19. HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

    Authors: Robert S. Rosenson, H. Bryan Brewer, M. John Chapman, Sergio Fazio, M. Mahmood Hussain, Anatol Kontush, Ronald M. Krauss, James D. Otvos, Alan T. Remaley, Ernst J. Schaefer - Clinical Chemistry 2011 cited by 513

  20. Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures

    Authors: W. Greg Miller, Gary L. Myers, Ikunosuke Sakurabayashi, Lorin M Bachmann, Samuel P. Caudill, Andrzej Dziekoński, Selvin H. Edwards, Mary M. Kimberly, William J. Korzun, Elizabeth Leary, Katsuyuki Nakajima, Masakazu Nakamura, Göran Nilsson, Robert D. Shamburek, George W. Vetrovec, G. Russell Warnick, Alan T. Remaley - Clinical Chemistry 2010 cited by 381

  21. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

    Authors: Michel R. Langlois, M. John Chapman, Christa M. Cobbaert, Samia Mora, Alan T. Remaley, Emilio Ros, Gerald F. Watts, Jan Borén, H Baum, Éric Bruckert, Alberico L. Catapano, Olivier Descamps, Arnold von Eckardstein, Pia R. Kamstrup, Genovefa Kolovou, Florian Kronenberg, Anne Langsted, Kari Pulkki, Nader Rifai, Grażyna Sypniewska, Olov Wiklund, Børge G. Nordestgaard - Clinical Chemistry 2018 cited by 258

  22. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

    Authors: Daniel Soffer, Nicholas Marston, Kevin C. Maki, Terry A. Jacobson, Vera Bittner, Jessica M. Peña, George Thanassoulis, Seth S. Martin, Carol F. Kirkpatrick, Salim S. Virani, Dave L. Dixon, Christie M. Ballantyne, Alan T. Remaley - Journal of clinical lipidology 2024 cited by 77

  23. Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

    Authors: Yudong Liu, Carmelo Carmona‐Rivera, Erica Moore, Nickie Seto, Jason S. Knight, Milton Pryor, Zhihong Yang, Saskia Hemmers, Alan T. Remaley, Kerri Mowen, Mariana J. Kaplan - Frontiers in Immunology 2018 cited by 120

  24. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism

    Authors: Anna Wolska, Richard L. Dunbar, Lita A. Freeman, Masako Ueda, Marcelo Amar, Denis Sviridov, Alan T. Remaley - Atherosclerosis 2017 cited by 224